City
Epaper

Development of gut microbiome prompts insusceptible response to COVID-19 severity: Study

By ANI | Published: January 16, 2021 8:36 PM

The research published in the journal Gut claims that the assortment and volume of microscopic organisms in the gut, known as the microbiome, may impact the seriousness of COVID-19 and the magnitude of the immune system reaction to the infection.

Open in App

The research published in the journal Gut claims that the assortment and volume of microscopic orgsms in the gut, known as the microbiome, may impact the seriousness of COVID-19 and the magnitude of the immune system reaction to the infection.

Irregular characteristics in the make-up of the microbiome may likewise be embroiled in persevering incendiary mfestations, named 'long COVID', according to the research.

COVID-19 is primarily a respiratory illness, but the evidence suggests that the gut may also have a role. As the gut is the largest immunological organ in the body and its resident microbes are known to influence immune responses, the researchers wanted to find out if the gut microbiome might also affect the immune system response to COVID-19 infection.

They, therefore, obtained blood and stool samples and medical records from 100 hospital inpatients with laboratory-confirmed COVID-19 infection between February and May 2020 and from 78 people without COVID-19 who were taking part in a microbiome study before the pandemic.

The severity of COVID-19 was classified as mild in the absence of x-ray evidence of pneumonia; moderate if pneumonia with fever and respiratory tract symptoms were detected; severe if patients found it very difficult to breathe normally; and critical if they needed mechcal ventilation or experienced organ failure requiring intensive care.

To characterise the gut microbiome, 41 of the COVID patients provided multiple stool samples while in hospital, 27 of whom provided serial stool samples up to 30 days after clearance of SARS-CoV-2, the virus responsible for COVID-19.

Analysis of all 274 stool samples showed that the make-up of the gut microbiome differed significantly between patients with and without COVID-19, irrespective of whether they had been treated with drugs, including antibiotics.

COVID patients had higher numbers of Ruminococcus gnavus, Ruminococcus torques and Bacteroides dorei species than people without the infection.And they had far fewer of the species that can influence immune system response, such as Bifidobacterium adolescentis, Faecalibacterium prausnitzii and Eubacterium rectale.

Lower numbers of F. prausnitzii and Bifidobacterium bifidum were particularly associated with infection severity after taking account of antibiotic use and patient age.And the numbers of these bacteria remained low in the samples collected up to 30 days after infected patients had cleared the virus from their bodies.

COVID-19 infection prompts the immune system to produce inflammatory cytokines in response. In some cases, this response can be excessive ('cytokine storm'), causing widespread tissue damage, septic shock, and multiorgan failure.

Analysis of the blood samples showed that the microbial imbalance found in the COVID patients was also associated with raised levels of inflammatory cytokines and blood markers of tissue damage, such as C-reactive protein and certain enzymes.

This suggests that the gut microbiome might influence the immune system response to COVID-19 infection and potentially affect disease severity and outcome, say the researchers.

"In light of reports that a subset of recovered patients with COVID-19 experience persistent symptoms, such as fatigue, dyspnoea [breathlessness] and joint pains, some over 80 days after initial onset of symptoms, we posit that the dysbiotic gut microbiome could contribute to immune-related health problems post-COVID-19," they write.

This is an observational study, and as such, can't establish cause, added to which the gut microbiome varies widely among different populations, so the changes observed in this study may not be applicable to other COVID patients elsewhere, caution the researchers.

But they point to mounting evidence showing that gut microbes are linked to inflammatory diseases within and beyond the gut.

And they conclude: "Bolstering of beneficial gut species depleted in COVID-19 could serve as a novel avenue to mitigate severe disease, underscoring the importance of managing patients' gut microbiota during and after COVID-19."

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentDeepika Padukone to Hailey Bieber, Happy Mother's Day to Our To-Be Mothers

NationalMallikarjun Kharge’s Bihar Visit Won’t Affect NDA: Samrat Choudhary

Tennis"Even if now it seems impossible": Rafael Nadal 'not clear' of French Open 2024 participation

Other SportsMainz ease relegation worries after stunning Dortmund in Bundesliga

EntertainmentKiara Advani shares sunkissed selfies from breezy beach vacation, don't miss her cute pout

Lifestyle Realted Stories

LifestyleMother's Day 2024 Special Quotes: Know What the Mothers of India's Icons Taught Us About Motherhood

LifestyleHealth Tips: Four Weight Loss Foods To Eat Before Bed

LifestyleSummer Skincare Solutions: Home Remedies for Oily Skin and Glow-Boosting Tips

LifestyleDoes Coffee Make You Poop in the Morning?

LifestyleHappy Mother's Day 2024: Unique and Trendy Gift Ideas for Your Mom